Securities Code: 300238
Securities Abbreviation: Guanhhao Bio
Announcement No.: 2026-041
Guanhhao Bio-tech Co., Ltd.
Announcement on Diluting Immediate Returns from Issuing Shares to Specific Objects via Simplified Procedures in 2026 and Taking Remedial Measures and Related Party Commitments (Revised Draft)
The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or significant omissions.
Important Notes:
-
The hypothetical analysis of financial indicators in this announcement by Guanhhao Bio-tech Co., Ltd. (hereinafter referred to as the "Company") does not constitute a profit forecast for the Company. The specific measures to compensate for the dilution of immediate returns formulated to address the risk of dilution do not guarantee the Company's future profits. Investors should not make investment decisions based on this. The Company shall not bear liability for compensation for losses incurred by investors making investment decisions based on this.
-
The number of shares and the completion time of the issuance of shares to specific objects via simplified procedures in 2026 (hereinafter referred to as the "Current Issuance") mentioned in this announcement are estimates and assumptions. The final outcome is subject to the approval and registration by the China Securities Regulatory Commission (CSRC) and the actual issuance situation. Please pay attention and be aware of investment risks.
In accordance with the "Opinions of the General Office of the State Council on Further Strengthening the Protection of the Legal Rights and Interests of Small and Medium Investors in the Capital Market" (Guo Ban Fa [2013] No. 110), the "Several Opinions of the State Council on Further Promoting the Healthy Development of the Capital Market" (Guo Fa [2014] No. 17), and the "Guiding Opinions on Matters Concerning the Dilution of Immediate Returns from Initial Public Offerings, Refinancing, and Major Asset Restructurings" (Announcement of the China Securities Regulatory Commission [2015] No. 31), in order to protect the interests of the vast number of investors, the Company has conducted a thorough analysis of the impact of the current issuance of shares to specific objects via simplified procedures on immediate returns and has formulated specific measures to compensate for the returns. The relevant parties of the Company have made commitments to ensure the effective implementation of the Company's measures to compensate for immediate returns. The specific situation is as follows:
I. Impact of the Current Issuance on the Company's Main Financial Indicators
(I) Assumptions and Explanations for Financial Calculations